Skip to main content
Vai all'homepage della Commissione europea (si apre in una nuova finestra)
italiano it
CORDIS - Risultati della ricerca dell’UE
CORDIS

Unlocking the tissue code: Understanding organ-specific regulation of CD8+ T cell immunity by eicosanoids

Descrizione del progetto

Modulazione delle cellule T killer mediante lipidi bioattivi organo-specifici

I linfociti T citotossici, chiamati anche cellule T CD8+ o cellule T killer, identificano e distruggono le cellule estranee o anomale. Tra queste sono comprese le cellule infettate da virus o batteri e le cellule tumorali. Per sfruttare questo «esercito» attraverso le immunoterapie è necessario capire come viene regolato. Il progetto EICO-CODE, finanziato dal CER, intende studiare l’ipotesi che gli eicosanoidi (lipidi bioattivi) specifici di un organo siano fattori rilasciati localmente e percepiti dalle cellule T CD8+, modulando le loro risposte. Il progetto caratterizzerà i profili degli eicosanoidi negli organi, i meccanismi di rilevamento degli eicosanoidi da parte delle cellule T, gli effetti sulle risposte delle cellule T CD8+ e il loro impatto sul potenziale protettivo delle cellule T. Le tecniche comprenderanno l’editing genico, il barcoding e il sequenziamento dell’RNA di una singola cellula.

Obiettivo

CD8+ T cells are critical for immunity against infection and cancer. Eliciting protective CD8+ T cell immunity is the main goal of many current and emerging immunotherapies aimed at treating these diseases, holding the promise to substantially improve patient outcomes. Evidence suggests that T cell regulation by tissue-derived factors is one of the key mechanisms influencing the protective potential of CD8+ T cell responses, however, the nature and molecular impact of these factors remains incompletely understood.

Building on our recent work, I propose that organ-specific regulation of CD8+ T cell immunity is driven by eicosanoids, a class of bioactive lipids, which act as tissue factors that locally shape CD8+ T cell differentiation and function. EICO-CODE aims to understand how eicosanoids shape CD8+ T cell responses in organs and to reveal their mechanistic implications for T cell immunity against cancer and viral infections. We will use newly developed methods for eicosanoid profiling and T cell eicosanoid sensing to define eicosanoid profiles across organs and identify how these locally provided factors are sensed by CD8+ T cells. We will further integrate approaches for T cell gene editing, T cell barcoding and single-cell RNA-sequencing with a unique set of organ-specific cancer and viral infection models, to reveal how eicosanoids modulate anti-cancer and anti-viral CD8+ T cell responses and test how this determines their protective potential.

This project will provide new mechanistic links between organ-derived bioactive lipid mediators and T cell immunity. These insights will influence our current understanding of how immune responses are adapted in different tissues and will help to identify new molecular targets and therapeutic strategies to enhance or reinvigorate protective immunity against cancer or infection.

Campo scientifico (EuroSciVoc)

Parole chiave

Programma(i)

Argomento(i)

Meccanismo di finanziamento

HORIZON-ERC - HORIZON ERC Grants

Vedi tutti i progetti finanziati nell’ambito di questo schema di finanziamento

Invito a presentare proposte

(si apre in una nuova finestra) ERC-2025-COG

Vedi tutti i progetti finanziati nell’ambito del bando

Istituzione ospitante

EBERHARD KARLS UNIVERSITAET TUEBINGEN
Contributo netto dell'UE
€ 1 986 850,00
Indirizzo
GESCHWISTER-SCHOLL-PLATZ
72074 Tuebingen
Germania
Regione
Baden-Württemberg Tübingen Tübingen, Landkreis
Tipo di attività
Higher or Secondary Education Establishments
Collegamenti
Costo totale
€ 1 986 850,00

Beneficiari (1)